STOCKSURGICAL & MEDICAL INSTRUMENTS & APPARATUSUpdated 2026-08-23
Here’s whether DexCom, Inc. (DXCM) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.24% over 10 days); RSI 63 — healthy momentum range; strong 1-year return of +14.5%; 3-month momentum positive (+28.1%). Currently 0.2% off its 52-week high. Score: +7/7.
DXCM is in a confirmed uptrend, trading above both its 50-day ($77.63) and 200-day ($69.32) moving averages. An RSI of 62.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +14.5% compares to +20.5% for SPY (trailed the market by 5.9%).
$10,000 invested 1 year ago→ $11,454 today
vs. S&P 500 (SPY) — same period trailed market by 5.9%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($69.32)
✓Above 50-day MA ($77.63)
✓RSI(14) neutral zone (30–70) — currently 62.7
✓Positive return (+14.5%)
✓Within 10% of period high (−0.2%)
Period Range $92.34
$54.11$92.56
RSI (14) 62.7
0 · OversoldOverbought · 100
Key Metrics
Price$92.34
Period Return+14.5%
Period High$92.56
Period Low$54.11
Drawdown−0.2%
MA-50$77.63
MA-200$69.32
RSI (14)62.7
Avg Volume (30d)5.2M
vs. SPYtrailed by 5.9%
Return Rank#441 of 999
Trend Signals
Price is above the 200-day moving average ($69.32)